Centers for Disease Control and Prevention | Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States |
---|---|
Vaccination considerations for persons with underlying medication conditions | Centers for Disease Control and Prevention |
When vaccine is limited, who should get vaccinated first? Centers for Disease Control and Prevention.
20Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations | Centers for Disease Control and Prevention |
---|---|
What to expect after getting a COVID-19 vaccine | Morbidity and Mortality Weekly Report |